Tumour Virus Research

Journal Title：Tumour Virus Research

Tumour Virus Research aims to provide a communication platform for researchers, clinical doctors, and public health experts, promote interdisciplinary collaboration, and accelerate the understanding of the mechanisms of viral carcinogenesis and the development of treatment methods. Its target readership includes but is not limited to virologists, oncologists, immunologists, biomedical scientists, clinical doctors, and public health professionals. This journal mainly publishes original research papers, review articles, briefs, viewpoints, and reviews. Its content involves but is not limited to exploring the molecular mechanisms of how viruses trigger malignant cell transformation; Report on new discoveries related to virus associated tumors, such as diagnostic markers or treatment methods; Introduce the latest developments in preventive and therapeutic vaccines for tumors caused by viruses.

《肿瘤病毒研究》旨在为研究人员、临床医生以及公共卫生专家提供一个交流平台，促进跨学科合作，加速病毒致癌机制的理解及治疗手段的发展。其目标读者群包括但不限于病毒学家、肿瘤学家、免疫学家、生物医学科学家、临床医生和公共卫生专业人员等。该刊主要发表原始研究论文、综述文章、简报、观点以及评论等类型的文章。其内容涉及但不限于以探究病毒如何引发细胞恶性转化的分子机制；报道有关病毒相关肿瘤的新发现，如诊断标志物或治疗方法；介绍针对病毒引起的肿瘤的预防性和治疗性疫苗的最新进展等。

Tumour Virus Research由Elsevier出版商出版，收稿方向涵盖Medicine - Infectious Diseases全领域，平均审稿速度 14 Weeks ，影响因子指数4.7，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。